logo
Watching "Apple Cider Vinegar" as a breast cancer survivor

Watching "Apple Cider Vinegar" as a breast cancer survivor

Yahoo22-02-2025

The popular new Netflix series, 'Apple Cider Vinegar,' based largely on the true story of Australian wellness influencer and fraudster Belle Gibson, affected me deeply. Gibson claimed her wellness treatments cured her terminal brain cancer, a brazen and consequential lie that risked the lives of her followers.
As a two-time breast cancer survivor, I know cancer treatments are not for the faint-hearted or non-compliant. But they have kept me — and millions of others — alive. Meanwhile, research shows patients who reject or delay the advice of their doctors are much more likely to die.
Today, after an ordeal including surgery, radiation and chemotherapy, I am 10 months cancer-free. And free, also, to binge this drama, enraged by the premise.
In the warped world inhabited by so-called wellness warriors, a strong person rejects conformity, and a weak person passively complies with the medical establishment. This argument distorts the global medical community, twisting "the establishment" into a nefarious money-making conspiracy. But while Big Pharma does rake in billions, cancer treatment is not a scam. And influencers who try to lure vulnerable people away from established science are toxic, in every sense of the word. Just as we have seen with Covid deniers and vaccine skeptics, disinformation can kill.
I could not watch any movie, series, program or TEDx talk on cancer while I was in the middle of my own treatments and recovery. There was nothing entertaining about the stories, or the characters — too many of whom died. I just knew I didn't want to be like them.
When I was first diagnosed with stage one breast cancer in 2006, I eagerly did everything my surgeon and oncologist told me to do. I got the lumpectomy. I submitted to the prescribed brachytherapy (internal seed radiation) twice daily for one week and many years of Tamoxifen, a hormone-blocking medication with uncomfortable and inconvenient side effects.
I wanted to live. And I trusted my doctors and medical team wanted me to live as much as I did.
A single mom with sole custody of three sons, then 13, 16 and 18, I wanted to see them all through high school, college, weddings, my grandchildren, and my eventual retirement.
Almost two decades later in June of 2023, a second breast cancer identified as triple negative, invasive, aggressive stage three showed up on my ultrasound. The three tumors measured seven centimeters altogether. Once again, I did absolutely everything my oncologist, surgeon and cardiologist ordered — including eliminating alcohol after reading about the link between drinking and cancer. I also gave up diet soda at the suggestion of my oncologist. Why not?
Because the truth is that cancer is scary. And highly motivating. The other main protagonist in 'Apple Cider Vinegar' is Milla Blake, a character who seems at least partly inspired by a real woman named Jessica Ainscough. Diagnosed with a rare cancer in her early 20s, Ainscough eventually stopped chemo and adopted an intense (and unproven) regimen of juices and coffee enemas. I deeply empathized with her honesty, vulnerability and courage as she searched for answers. She was aiming to fight for herself, not build a wellness empire based on lies.
But Ainscough also reportedly convinced her mother to forgo doctor recommendations and try the alternative therapy route. Her mother died from breast cancer in 2013. Ainscough would succumb to her own cancer a few years later. A tragedy layered on top of a tragedy.
The U.S. Centers for Disease Control and Prevention report that in 2022, the latest year numbers are available, over 600,000 people in the United States died from cancer. There are 18 million people, according to the American Cancer Society, with a history of cancer who are still alive.
Survival rates vary by cancer type, diagnosis timeline and various other personal variants. But the overall five-year survival rate for breast cancer in women is 90% — if those women follow the recommended surgery, chemotherapy and radiation protocol.
On the other hand, the Mayo Clinic notes that alternative treatments may be able to help with some symptoms, but they are not cures. If they were, doctors would use them.
As accurately presented in the series by screenwriter Samantha Strauss, chemotherapy is almost intolerable; my own treatments were cut short and surgery for a radical mastectomy moved up more than three months because my system could not handle the stress.
I also went completely bald, just as the character Lucy did in the series. I wore a wig for a bit, until my hair began to grow back months after radiation ended. Chemo gave me mouth sores and made everything taste like gasoline; I ultimately lost more than 30 pounds.
And still, I listened to the experts. Any anger I felt was directed at my cancer, not at my doctors. Unlike in most every other aspect of my professional and personal life, when dealing with cancer, I was completely obedient.
A number of my friends have had their own cancer experiences, and I adamantly advise them to do everything their doctors and nurses recommend. I darkly joke that I spent my 30s sending flowers to my friends in hospitals having babies; in my 60s, I send flowers to my friends in hospitals having surgeries.
Ultimately, the tragedies presented in 'Apple Cider Vinegar' are real. But there is nothing inherently weak about following the science. And nothing inherently brave about ignoring it.
This article was originally published on MSNBC.com

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Australia's Monash IVF reports second embryo incident in two months
Australia's Monash IVF reports second embryo incident in two months

Yahoo

time2 hours ago

  • Yahoo

Australia's Monash IVF reports second embryo incident in two months

(Reuters) -Australian fertility group Monash IVF on Tuesday reported a new incident related to an embryo transfer, within a couple of months after reporting a similar case where a doctor accidentally implanted the wrong embryo. The latest incident, which occurred on June 5 at the company's Clayton laboratory, has been reported to regulatory bodies and the company's insurer, Monash said, issuing an apology to the impacted couple. The company is also conducting an internal investigation. The firm added that it is implementing additional verification processes and patient confirmation safeguards to prevent similar incidents in the future. The clinic owner in April reported a similar incident where an Australian woman gave birth to a stranger's baby due to a Monash fertility doctor's error. Shares of Monash are down about 31% since the news. The mix-up has drawn attention to an industry that was largely self-regulated until recently and raised concerns about security protocols at IVF clinics. The facilities are regulated by a mix of Australian industry bodies and state government agencies.

Berkshire Hathaway Specialty Insurance Launches Life Science, BioTech & Pharmaceutical (LBP) Management Liability Policy in Australia
Berkshire Hathaway Specialty Insurance Launches Life Science, BioTech & Pharmaceutical (LBP) Management Liability Policy in Australia

Yahoo

time3 hours ago

  • Yahoo

Berkshire Hathaway Specialty Insurance Launches Life Science, BioTech & Pharmaceutical (LBP) Management Liability Policy in Australia

BOSTON & SYDNEY, June 09, 2025--(BUSINESS WIRE)--Berkshire Hathaway Specialty Insurance (BHSI) today announced the introduction of a Management Liability Insurance Policy tailored expressly for Life Science, BioTech and Pharmaceutical (LBP) companies in Australia. "The new LBP Management Liability Policy reflects our commitment to Australia's thriving life sciences community and our deep understanding of the challenges start-ups face at every stage of their journey," said Jessica Jefferies, Underwriting Manager, National Brokers, Executive & Professional Lines, BHSI Australia. "Life Sciences is one of the most promising industries in Australia and we are thrilled to be able to provide an innovative solution to support the industry". BHSI's new LBP Management Liability Insurance Policy is specifically for the R&D ecosystem – all stakeholders in Australia's diverse and energetic life sciences sector. The new product offers enhanced cover tailored for life sciences companies, with coverage not found in standard Management Liability policies. BHSI's solution will extend cover and ensure Directors, Officers, Scientific and Medical Advisory Boards all get the benefit of cover as they develop cutting-edge solutions globally. With an understanding of the funding requirements, the product provides two key elements of protection, extending cover for private capital raisings, and not excluding cover in the event of the Company's insolvency. With many Australian life sciences companies looking abroad for clinical development, BHSI's offering has the ability to extend protection to U.S. exposures, recognising the frequent pursuit of FDA approvals by Australian firms. The new solution expands BHSI's existing Management Liability policy wording for private companies and not-for-profits. BHSI is a leading market for Directors and Officers Liability insurance for ASX-listed life sciences companies in Australia. This launch extends that expertise and forms part of BHSI's strategy to provide tailored support for biotech and pharmaceutical customers from start-up to scale. To learn more, contact Berkshire Hathaway Specialty Insurance Company (incorporated in Nebraska, USA) ABN 84 600 643 034, AFS Licence No. 466713 ( provides commercial property, casualty, healthcare professional liability, executive and professional lines, transactional liability, surety, marine, travel, programs, accident & health, medical stop loss, homeowners, and multinational insurance. The actual and final terms of coverage for all product lines may vary. Berkshire Hathaway Specialty Insurance Company holds financial strength ratings of A++ from AM Best and AA+ from Standard & Poor's. Based in Boston, Berkshire Hathaway Specialty Insurance has offices in Atlanta, Boston, Chicago, Columbia, Dallas, Houston, Indianapolis, Irvine, Los Angeles, New York, Plymouth Meeting, San Francisco, San Ramon, Seattle, Stevens Point, Adelaide, Auckland, Barcelona, Brisbane, Brussels, Calgary, Cologne, Dubai, Dublin, Frankfurt, Hamburg, Hong Kong, Kuala Lumpur, London, Lyon, Macau, Madrid, Manchester, Melbourne, Milan, Munich, Paris, Perth, Singapore, Stockholm, Sydney, Toronto, and Zurich. View source version on Contacts MEDIA CONTACTJoAnn Lee / +1 617.936.2937

Berkshire Hathaway Specialty Insurance Launches Life Science, BioTech & Pharmaceutical (LBP) Management Liability Policy in Australia
Berkshire Hathaway Specialty Insurance Launches Life Science, BioTech & Pharmaceutical (LBP) Management Liability Policy in Australia

Business Wire

time3 hours ago

  • Business Wire

Berkshire Hathaway Specialty Insurance Launches Life Science, BioTech & Pharmaceutical (LBP) Management Liability Policy in Australia

BOSTON & SYDNEY--(BUSINESS WIRE)--Berkshire Hathaway Specialty Insurance (BHSI) today announced the introduction of a Management Liability Insurance Policy tailored expressly for Life Science, BioTech and Pharmaceutical (LBP) companies in Australia. 'The new LBP Management Liability Policy reflects our commitment to Australia's thriving life sciences community and our deep understanding of the challenges start-ups face at every stage of their journey,' said Jessica Jefferies, Underwriting Manager, National Brokers, Executive & Professional Lines, BHSI Australia. 'Life Sciences is one of the most promising industries in Australia and we are thrilled to be able to provide an innovative solution to support the industry'. BHSI's new LBP Management Liability Insurance Policy is specifically for the R&D ecosystem – all stakeholders in Australia's diverse and energetic life sciences sector. The new product offers enhanced cover tailored for life sciences companies, with coverage not found in standard Management Liability policies. BHSI's solution will extend cover and ensure Directors, Officers, Scientific and Medical Advisory Boards all get the benefit of cover as they develop cutting-edge solutions globally. With an understanding of the funding requirements, the product provides two key elements of protection, extending cover for private capital raisings, and not excluding cover in the event of the Company's insolvency. With many Australian life sciences companies looking abroad for clinical development, BHSI's offering has the ability to extend protection to U.S. exposures, recognising the frequent pursuit of FDA approvals by Australian firms. The new solution expands BHSI's existing Management Liability policy wording for private companies and not-for-profits. BHSI is a leading market for Directors and Officers Liability insurance for ASX-listed life sciences companies in Australia. This launch extends that expertise and forms part of BHSI's strategy to provide tailored support for biotech and pharmaceutical customers from start-up to scale. To learn more, contact Berkshire Hathaway Specialty Insurance Company (incorporated in Nebraska, USA) ABN 84 600 643 034, AFS Licence No. 466713 ( provides commercial property, casualty, healthcare professional liability, executive and professional lines, transactional liability, surety, marine, travel, programs, accident & health, medical stop loss, homeowners, and multinational insurance. The actual and final terms of coverage for all product lines may vary. Berkshire Hathaway Specialty Insurance Company holds financial strength ratings of A++ from AM Best and AA+ from Standard & Poor's. Based in Boston, Berkshire Hathaway Specialty Insurance has offices in Atlanta, Boston, Chicago, Columbia, Dallas, Houston, Indianapolis, Irvine, Los Angeles, New York, Plymouth Meeting, San Francisco, San Ramon, Seattle, Stevens Point, Adelaide, Auckland, Barcelona, Brisbane, Brussels, Calgary, Cologne, Dubai, Dublin, Frankfurt, Hamburg, Hong Kong, Kuala Lumpur, London, Lyon, Macau, Madrid, Manchester, Melbourne, Milan, Munich, Paris, Perth, Singapore, Stockholm, Sydney, Toronto, and Zurich.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store